Coltene Valuation Multiples

Discover revenue and EBITDA valuation multiples for Coltene and similar public comparables like Perspective Therapeutics, Stratec, Advanced Technology Company, VieMed and more.

Coltene Overview

About Coltene

Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions.


Founded

2005

HQ

Switzerland

Employees

1.2K

Financials (LTM)

Revenue: $296M
EBITDA: $35M

EV

$395M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Coltene Financials

Coltene reported last 12-month revenue of $296M and EBITDA of $35M.

In the same LTM period, Coltene generated $192M in gross profit, $35M in EBITDA, and $20M in net income.

Revenue (LTM)


Coltene P&L

In the most recent fiscal year, Coltene reported revenue of $297M and EBITDA of $32M.

Coltene is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 11%, and net margin of 6%.

See analyst estimates for Coltene
LTMLast FY202320242025202620272028
Revenue$296M$297M$298M$308M$297M
Gross Profit$192M$185M$180M$193M$185M
Gross Margin65%62%60%63%62%
EBITDA$35M$32M$29M$42M$32M
EBITDA Margin12%11%10%14%11%
EBIT Margin9%9%8%11%9%
Net Profit$20M$18M$15M$25M$18M
Net Margin7%6%5%8%6%
Net Debt-$33M---

Financial data powered by Morningstar, Inc.

Coltene Stock Performance

Coltene has current market cap of $353M, and enterprise value of $395M.

Market Cap Evolution


Coltene's stock price is $59.13.

Coltene share price increased by 1.3% in the last 30 days, and by 5.5% in the last year.

Coltene has an EPS (earnings per share) of $3.09.

See more trading valuation data for Coltene
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$395M$353M1.3%1.3%-6.6%5.5%$3.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Coltene Valuation Multiples

Coltene trades at 1.3x EV/Revenue multiple, and 11.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Coltene

EV / Revenue (LTM)


Coltene Financial Valuation Multiples

As of September 2, 2026, Coltene has market cap of $353M and EV of $395M.

Coltene has a P/E ratio of 17.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.3x1.3x1.3x1.3x1.3x
EV/EBITDA11.3x12.2x13.5x9.4x12.2x
EV/EBIT15.2x15.2x16.4x12.0x15.2x
EV/Gross Profit2.1x2.1x2.2x2.0x2.1x
P/E17.9x19.1x24.1x14.0x19.1x
EV/FCF20.8x41.5x18.6x14.1x41.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Coltene Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Coltene Margins & Growth Rates

Coltene decreased revenue by 2% but EBITDA grew by 6% in the last fiscal year.

In the most recent fiscal year, Coltene reported gross margin of 62%, EBITDA margin of 11%, and net margin of 6%.

See estimated margins and future growth rates for Coltene

Coltene Margins

Last FY202420252026202720282029
Gross Margin62%63%62%-
EBITDA Margin11%14%11%12%
EBIT Margin9%11%9%9%
Net Margin6%8%6%7%
FCF Margin3%9%3%7%

Coltene Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)3%(3%)(2%)
Gross Profit Growth-7%(4%)-
EBITDA Growth6%44%(23%)6%
EBIT Growth(2%)37%(21%)(2%)
Net Profit Growth9%71%(27%)9%
FCF Growth120%32%(66%)120%

Data powered by FactSet, Inc. and Morningstar, Inc.

Coltene Operational KPIs

Coltene's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Coltene's Rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Coltene's Rule of X is 6% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Coltene
LTMLast FY202320242025202620272028
Rule of 4011%10%---
Bessemer Rule of X10%6%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-3%3%3%3%
G&A Expenses to Revenue-9%9%10%9%
Opex to Revenue-53%52%52%53%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Coltene Competitors

Coltene competitors include Perspective Therapeutics, Stratec, Advanced Technology Company, VieMed, Vicenne, Abbott Pakistan, Medios, IVF hartmann, Universal Vision and Orthofix Medical.

Most Coltene public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Perspective Therapeutics-229.6x(1.2x)(1.0x)
Stratec1.6x1.5x12.0x10.1x
Advanced Technology Company1.8x-168.7x-
VieMed1.3x1.1x6.6x5.3x
Vicenne2.7x2.3x11.7x-
Abbott Pakistan1.1x-5.6x-
Medios0.2x0.2x4.7x4.5x
IVF hartmann1.2x-7.7x-

This data is available for Pro users. Sign up to see all Coltene competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Coltene

When was Coltene founded?Coltene was founded in 2005.
Where is Coltene headquartered?Coltene is headquartered in Switzerland.
How many employees does Coltene have?As of today, Coltene has over 1K employees.
Is Coltene publicly listed?Yes, Coltene is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Coltene?Coltene trades under CLTN ticker.
When did Coltene go public?Coltene went public in 2006.
Who are competitors of Coltene?Coltene main competitors include Perspective Therapeutics, Stratec, Advanced Technology Company, VieMed, Vicenne, Abbott Pakistan, Medios, IVF hartmann, Universal Vision, Orthofix Medical.
What is the current market cap of Coltene?Coltene's current market cap is $353M.
What is the current revenue of Coltene?Coltene's last 12 months revenue is $296M.
What is the current revenue growth of Coltene?Coltene revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Coltene?Current revenue multiple of Coltene is 1.3x.
What is the current EBITDA of Coltene?Coltene's last 12 months EBITDA is $35M.
What is Coltene's EBITDA margin?Coltene's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Coltene?Current EBITDA multiple of Coltene is 11.3x.
What is the current FCF of Coltene?Coltene's last 12 months FCF is $19M.
What is Coltene's FCF margin?Coltene's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Coltene?Current FCF multiple of Coltene is 20.8x.
How many companies Coltene has acquired to date?Coltene hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Coltene has invested to date?Coltene hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Coltene

Lists including Coltene

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial